{"doi":"10.5114/hpc.2025.152237","title":"MODERN TECHNOLOGIES IN MONITORING AND TREATING TYPE 2 DIABETES IN THE ELDERLY","abstract":"<jats:p>Modern technologies are increasingly being used in medicine. The following review focuses on their application in the treatment of type 2 diabetes, with a special focus on the elderly. The cornerstone of therapy is regular glucose measurement, which until now has relied mainly on self-monitoring. In contrast, continuous glycemic monitoring systems are increasingly being used. App-linked devices significantly improve a patient's quality of life, but advanced technology can be difficult for older patients. Another aspect of diabetes treatment is diet. Maintaining a diet can also be facilitated by apps and artificial intelligence (AI). The advantages of technologies such as voice-based AI and mHealth include ease of accessibility, effective therapy control, and reduced healthcare costs. This is especially important in older patients with multimorbidity and a difficult disease course. However, it is crucial to educate older patients and their caregivers to implement these solutions into daily therapy. Support from doctors, families, and interface customization will make them easier to use. AI-based systems will soon be a mainstay of diabetes therapy.</jats:p>","journal":"Health Problems of Civilization","year":2025,"id":644655,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1678094,"name":"Agnieszka Sawina","orcid":null,"position":1,"is_corresponding":false},{"id":1678095,"name":"Sara Rakotoarison","orcid":null,"position":2,"is_corresponding":false},{"id":1678096,"name":"Jakub Fiegler-Rudol","orcid":null,"position":3,"is_corresponding":false},{"id":1678097,"name":"Karolina Lau","orcid":null,"position":4,"is_corresponding":false},{"id":1678098,"name":"Janusz Kasperczyk","orcid":null,"position":5,"is_corresponding":false},{"id":1678093,"name":"Elżbieta Stec-Sawina","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"MODERN TECHNOLOGIES IN MONITORING AND TREATING TYPE 2 DIABETES IN THE ELDERLY","abstract":"<jats:p>Modern technologies are increasingly being used in medicine. The following review focuses on their application in the treatment of type 2 diabetes, with a special focus on the elderly. The cornerstone of therapy is regular glucose measurement, which until now has relied mainly on self-monitoring. In contrast, continuous glycemic monitoring systems are increasingly being used. App-linked devices significantly improve a patient's quality of life, but advanced technology can be difficult for older patients. Another aspect of diabetes treatment is diet. Maintaining a diet can also be facilitated by apps and artificial intelligence (AI). The advantages of technologies such as voice-based AI and mHealth include ease of accessibility, effective therapy control, and reduced healthcare costs. This is especially important in older patients with multimorbidity and a difficult disease course. However, it is crucial to educate older patients and their caregivers to implement these solutions into daily therapy. Support from doctors, families, and interface customization will make them easier to use. AI-based systems will soon be a mainstay of diabetes therapy.</jats:p>","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19767382","pmcid":null,"openalex_id":"https://openalex.org/W4411608180","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.19804035,"influential_citations":0,"citation_trend":[],"oa_status":"gold","license":"cc-by-nc-sa","oa_locations":[{"url":"https://www.termedia.pl/Journal/-99/pdf-56315-10?filename=Sawina et al.pdf","host_type":"journal"},{"url":"https://www.termedia.pl/Journal/-99/pdf-56315-10?filename=Sawina et al.pdf","host_type":"publisher"},{"url":"https://hpc.edu.pl/pdf-207302-134777","host_type":"publisher"},{"url":"https://doi.org/10.5114/hpc.2025.152237","host_type":"journal"}],"fields_of_study":["Diabetes Management and Research"],"mesh_terms":[],"keywords":["Type 2 diabetes","Medicine","Diabetes mellitus","Intensive care medicine","Gerontology","Endocrinology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-09T01:45:43.510072Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}